SHANE WATTS: Open Payments
NPI 1285385005 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,086 in 210 payments from 20 companies in 2025. Trend: 2023 $3,665 · 2024 $4,109 · 2025 $3,086
Food & beverage: $3,086
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $496 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $368 |
| Alkermes, Inc. | 21 | $310 |
| Lundbeck LLC | 14 | $278 |
| Vanda Pharmaceuticals Inc. | 20 | $264 |
| Neos Therapeutics, LP | 30 | $263 |
| Bausch Health US, LLC | 17 | $235 |
| Noven Therapeutics, LLC | 11 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $156 |
| Otsuka America Pharmaceutical, Inc. | 8 | $136 |
Products named: VRAYLAR, REXULTI, CAPLYTA, Adzenys XR-ODT, HETLIOZ, APLENZIN, Xelstrym, TRINTELLIX.
Industry payments across KY — which companies pay providers there.
